Qiagen N.V. (QGEN)
Qiagen N.V. - QIAGEN announces adjustment of conversion price under its US$500,000,000 Convertible Bonds due 2027
Qiagen N.V. (QGEN)
Qiagen N.V. - QIAGEN announces adjustment of conversion price under its US$500,000,000 Convertible Bonds due 2031
INmune Bio Inc. (INMB)
Auxly Cannabis Group Inc. (CBWTF)
Auxly Announces Results of Annual General Meeting of Shareholders
Intuitive Surgical Inc (ISRG)
Intuitive’s da Vinci 5 Surgical System Receives CE Mark
Veradigm Inc (MDRX)
Iovance Biotherapeutics Inc (IOVA)
IOVA Shareholders Have the Right to Lead the Iovance Biotherapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ELV
Sarepta Therapeutics Inc (SRPT)
SRPT Shareholders Have the Right to Lead the Sarepta Therapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group Before the Final Deadline - SRPT
Inspira Technologies Oxy BHN (IINNW)
Inspira Technologies Oxy BHN (IINN)
Inspira Technologies Secures $22.5 Million Purchase Order, Launches Full Revenue Execution Phase
VYNE Therapeutics Inc. (VYNE)
VYNE Therapeutics Updates for 07/02/2025
Cyclacel Pharmaceuticals Inc. (CYCCP)
Cyclacel Pharmaceuticals Announces Stock Split
Sonnet BioTherapeutics Holdings Inc. (SONN)
New Form 8-K - Sonnet BioTherapeutics Holdings, Inc. Filed: 2025-07-02 AccNo: 0001641172-25-017478 Size: 492 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 3.02: Unregistered Sales of Equity Securities Item …
Cyclacel Pharmaceuticals Inc. (CYCCP)
Zynex Inc (ZYXI)
New Form 8-K - ZYNEX INC Filed: 2025-07-02 AccNo: 0001558370-25-009040 Size: 963 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits